改善住院肝硬化护理质量的电子干预措施：一项前瞻性评估。
Electronic Interventions to Improve Quality for Inpatient Cirrhosis Care: A Prospective Evaluation.
作者信息
Romain Dustin, Hao Shengchen, Grzyb Katie, Bashaw Linda, Parikh Neehar D, Tapper Elliot B
机构信息
Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan.
出版信息
Am J Gastroenterol. 2025 Jan 29;120(9):2198-2200. doi: 10.14309/ajg.0000000000003334.
Abstract
INTRODUCTION
Efforts to improve adherence to quality measures in cirrhosis care are encouraged by American Association for the Study of Liver Diseases (AASLD) to improve clinical outcomes.
METHODS
We prospectively evaluated 2 best practice advisory (BPA) interventions to alert clinicians caring for patients with cirrhosis and acute variceal hemorrhage or spontaneous bacterial peritonitis.
RESULTS
Our BPAs increased utilization. Ceftriaxone use was associated with adverse outcomes such as more blood product and broad-spectrum antibiotic use. The albumin BPA was associated with reduced mortality.
DISCUSSION
BPAs should be used with care and are best in settings with low baseline utilization of quality indicators.
摘要
引言
美国肝病研究协会（AASLD）鼓励采取措施提高肝硬化护理质量指标的依从性，以改善临床结局。
方法
我们前瞻性评估了2种最佳实践建议（BPA）干预措施，以提醒照顾肝硬化合并急性静脉曲张出血或自发性细菌性腹膜炎患者的临床医生。
结果
我们的BPA提高了利用率。头孢曲松的使用与更多血液制品和广谱抗生素使用等不良结局相关。白蛋白BPA与死亡率降低相关。
讨论
BPA的使用应谨慎，在质量指标基线利用率较低的环境中使用效果最佳。
相似文献
1
Electronic Interventions to Improve Quality for Inpatient Cirrhosis Care: A Prospective Evaluation.改善住院肝硬化护理质量的电子干预措施：一项前瞻性评估。
Am J Gastroenterol. 2025 Jan 29;120(9):2198-2200. doi: 10.14309/ajg.0000000000003334.
2
Antibiotic prophylaxis to prevent spontaneous bacterial peritonitis in people with liver cirrhosis: a network meta-analysis.抗生素预防肝硬化患者自发性细菌性腹膜炎：一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 16;1(1):CD013125. doi: 10.1002/14651858.CD013125.pub2.
3
Antibiotic treatment for spontaneous bacterial peritonitis in people with decompensated liver cirrhosis: a network meta-analysis.失代偿期肝硬化患者自发性细菌性腹膜炎的抗生素治疗：一项网状Meta分析
Cochrane Database Syst Rev. 2019 Sep 16;9(9):CD013120. doi: 10.1002/14651858.CD013120.pub2.
4
Treatment for bleeding oesophageal varices in people with decompensated liver cirrhosis: a network meta-analysis.失代偿期肝硬化患者食管静脉曲张出血的治疗：网状荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 10;4(4):CD013155. doi: 10.1002/14651858.CD013155.pub2.
5
Endoscopic injection of cyanoacrylate glue versus other endoscopic procedures for acute bleeding gastric varices in people with portal hypertension.内镜下注射氰基丙烯酸酯胶与其他内镜手术治疗门静脉高压症患者急性出血性胃静脉曲张的比较。
Cochrane Database Syst Rev. 2015 May 12;2015(5):CD010180. doi: 10.1002/14651858.CD010180.pub2.
6
Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis.肝硬化失代偿期食管静脉曲张出血患者的二级预防：网络荟萃分析。
Cochrane Database Syst Rev. 2021 Mar 30;3(3):CD013122. doi: 10.1002/14651858.CD013122.pub2.
7
Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis.肝硬化食管静脉曲张患者的静脉曲张出血一级预防：网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 6;4(4):CD013121. doi: 10.1002/14651858.CD013121.pub2.
8
Granulocyte colony-stimulating factor with or without stem or progenitor cell or growth factors infusion for people with compensated or decompensated advanced chronic liver disease.粒细胞集落刺激因子联合或不联合干细胞或祖细胞或生长因子输注治疗代偿期或失代偿期晚期慢性肝病患者。
Cochrane Database Syst Rev. 2023 Jun 6;6(6):CD013532. doi: 10.1002/14651858.CD013532.pub2.
9
Pre-emptive TIPS for gastric variceal bleeding in patients with cirrhosis (GAVAPROSEC): an open-label randomised clinical trial.肝硬化患者胃静脉曲张出血的预先性经颈静脉肝内门体分流术（GAVAPROSEC）：一项开放标签随机临床试验
Lancet Gastroenterol Hepatol. 2025 Aug;10(8):726-733. doi: 10.1016/S2468-1253(25)00156-6. Epub 2025 Jun 12.
10
Expanded polytetrafluoroethylene (ePTFE)-covered stents versus bare stents for transjugular intrahepatic portosystemic shunt in people with liver cirrhosis.聚四氟乙烯覆膜支架与裸支架经颈静脉肝内门体分流术治疗肝硬化的效果比较。
Cochrane Database Syst Rev. 2023 Aug 2;8(8):CD012358. doi: 10.1002/14651858.CD012358.pub2.
本文引用的文献
1
A randomized study of ceftriaxone for the prevention of infections in hospitalized patients with advanced cirrhosis.一项头孢曲松预防晚期肝硬化住院患者感染的随机研究。
Hepatol Commun. 2024 Jan 5;8(1). doi: 10.1097/HC9.0000000000000356. eCollection 2024 Jan 1.
2
Antimicrobial prophylaxis in decompensated cirrhosis: friend or foe?失代偿期肝硬化的抗菌预防：是福是祸？
Hepatol Commun. 2023 Aug 31;7(9). doi: 10.1097/HC9.0000000000000228. eCollection 2023 Sep 1.
3
Diagnosis and Management of Cirrhosis and Its Complications: A Review.肝硬化及其并发症的诊断与管理：综述。
JAMA. 2023 May 9;329(18):1589-1602. doi: 10.1001/jama.2023.5997.
4
The impact of multidrug-resistant microorganisms on critically ill patients with cirrhosis in the intensive care unit: a cohort study.多药耐药微生物对 ICU 肝硬化危重症患者的影响：一项队列研究。
Hepatol Commun. 2023 Jan 20;7(2):e0038. doi: 10.1097/HC9.0000000000000038. eCollection 2023 Feb 1.
5
An Electronic Decision Support Intervention Reduces Readmissions for Patients With Cirrhosis.电子决策支持干预可降低肝硬化患者的再入院率。
Am J Gastroenterol. 2022 Mar 1;117(3):491-494. doi: 10.14309/ajg.0000000000001608.
6
Inpatient Gastroenterology Consultation and Outcomes of Cirrhosis-Related Hospitalizations in Two Large National Cohorts.在两个大型国家队列中，住院患者的消化内科会诊与肝硬化相关住院治疗结局的关系。
Dig Dis Sci. 2022 Jun;67(6):2094-2104. doi: 10.1007/s10620-021-07150-8. Epub 2021 Aug 10.
7
Impact of Inpatient Attending Specialty and Gastroenterology Consultation on Quality of Care of Patients Hospitalized with Decompensated Cirrhosis.住院主治医生专业和胃肠病学咨询对肝硬化失代偿患者的护理质量的影响。
Am J Med. 2021 Oct;134(10):1270-1277.e2. doi: 10.1016/j.amjmed.2021.05.010. Epub 2021 Jun 16.
8
Suboptimal Implementation of Evidence-based Therapy for Acute Variceal Hemorrhage: A Systematic Review of Observational Studies.证据为基础的急性静脉曲张出血治疗的实施不足：观察性研究的系统评价。
Clin Gastroenterol Hepatol. 2017 Sep;15(9):1373-1381.e7. doi: 10.1016/j.cgh.2017.02.018. Epub 2017 Feb 27.
9
Building Effective Quality Improvement Programs for Liver Disease: A Systematic Review of Quality Improvement Initiatives.构建有效的肝脏疾病质量改进计划：质量改进举措的系统评价。
Clin Gastroenterol Hepatol. 2016 Sep;14(9):1256-1265.e3. doi: 10.1016/j.cgh.2016.04.020. Epub 2016 Apr 19.
10
A Quality Improvement Initiative Reduces 30-Day Rate of Readmission for Patients With Cirrhosis.一项质量改进举措降低了肝硬化患者的30天再入院率。
Clin Gastroenterol Hepatol. 2016 May;14(5):753-9. doi: 10.1016/j.cgh.2015.08.041. Epub 2015 Sep 25.
Zotero 插件